437 related articles for article (PubMed ID: 25839704)
1. Lung Cancer Prognosis in Elderly Solid Organ Transplant Recipients.
Sigel K; Veluswamy R; Krauskopf K; Mehrotra A; Mhango G; Sigel C; Wisnivesky J
Transplantation; 2015 Oct; 99(10):2181-9. PubMed ID: 25839704
[TBL] [Abstract][Full Text] [Related]
2. Prognosis in HIV-infected patients with non-small cell lung cancer.
Sigel K; Crothers K; Dubrow R; Krauskopf K; Jao J; Sigel C; Moskowitz A; Wisnivesky J
Br J Cancer; 2013 Oct; 109(7):1974-80. PubMed ID: 24022194
[TBL] [Abstract][Full Text] [Related]
3. Thermal ablation matches sublobar resection outcomes in older patients with early-stage non-small cell lung cancer.
Kwan SW; Mortell KE; Talenfeld AD; Brunner MC
J Vasc Interv Radiol; 2014 Jan; 25(1):1-9.e1. PubMed ID: 24365502
[TBL] [Abstract][Full Text] [Related]
4. Prognostic impact of malignant pleural effusion at presentation in patients with metastatic non-small-cell lung cancer.
Morgensztern D; Waqar S; Subramanian J; Trinkaus K; Govindan R
J Thorac Oncol; 2012 Oct; 7(10):1485-9. PubMed ID: 22982649
[TBL] [Abstract][Full Text] [Related]
5. Comparison of demographic characteristics, surgical resection patterns, and survival outcomes for veterans and nonveterans with non-small cell lung cancer in the Pacific Northwest.
Zeliadt SB; Sekaran NK; Hu EY; Slatore CC; Au DH; Backhus L; Wu DY; Crawford J; Lyman GH; Dale DC
J Thorac Oncol; 2011 Oct; 6(10):1726-32. PubMed ID: 21857253
[TBL] [Abstract][Full Text] [Related]
6. Incidence of post-transplant malignancy among 674 solid-organ-transplant recipients at a single center.
Mihalov ML; Gattuso P; Abraham K; Holmes EW; Reddy V
Clin Transplant; 1996 Jun; 10(3):248-55. PubMed ID: 8826661
[TBL] [Abstract][Full Text] [Related]
7. Sebaceous Carcinoma Incidence and Survival Among Solid Organ Transplant Recipients in the United States, 1987-2017.
Sargen MR; Cahoon EK; Lynch CF; Tucker MA; Goldstein AM; Engels EA
JAMA Dermatol; 2020 Dec; 156(12):1307-1314. PubMed ID: 33146669
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of tumor size in patients with stage III non-small-cell lung cancer: a surveillance, epidemiology, and end results (SEER) survey from 1998 to 2003.
Morgensztern D; Waqar S; Subramanian J; Gao F; Trinkaus K; Govindan R
J Thorac Oncol; 2012 Oct; 7(10):1479-84. PubMed ID: 22982648
[TBL] [Abstract][Full Text] [Related]
9. Survival after second primary lung cancer: a population-based study of 187 Hodgkin lymphoma patients.
Milano MT; Li H; Constine LS; Travis LB
Cancer; 2011 Dec; 117(24):5538-47. PubMed ID: 21692074
[TBL] [Abstract][Full Text] [Related]
10. Predictors of survival for younger patients less than 50 years of age with non-small cell lung cancer (NSCLC): a California Cancer Registry analysis.
Lara MS; Brunson A; Wun T; Tomlinson B; Qi L; Cress R; Gandara DR; Kelly K
Lung Cancer; 2014 Aug; 85(2):264-9. PubMed ID: 24878033
[TBL] [Abstract][Full Text] [Related]
11. Periocular Skin Cancer in Solid Organ Transplant Recipients.
Perry JD; Polito SC; Chundury RV; Singh AD; Fritz MA; Vidimos AT; Gastman BR; Koyfman SA
Ophthalmology; 2016 Jan; 123(1):203-8. PubMed ID: 26520170
[TBL] [Abstract][Full Text] [Related]
12. Conditional cancer-specific versus cardiovascular-specific survival after lobectomy for stage I non-small cell lung cancer.
Groth SS; Rueth NM; Hodges JS; Habermann EB; Andrade RS; D'Cunha J; Maddaus MA
Ann Thorac Surg; 2010 Aug; 90(2):375-82. PubMed ID: 20667314
[TBL] [Abstract][Full Text] [Related]
13. Carcinoma NOS is a common histologic diagnosis and is increasing in proportion among non-small cell lung cancer histologies.
Ou SH; Zell JA
J Thorac Oncol; 2009 Oct; 4(10):1202-11. PubMed ID: 19701111
[TBL] [Abstract][Full Text] [Related]
14. Definitive radiotherapy for stage I nonsmall cell lung cancer: a population-based study of survival.
Milano MT; Zhang H; Usuki KY; Singh DP; Chen Y
Cancer; 2012 Nov; 118(22):5572-9. PubMed ID: 22544655
[TBL] [Abstract][Full Text] [Related]
15. Treatment disparities for disabled medicare beneficiaries with stage I non-small cell lung cancer.
Iezzoni LI; Ngo LH; Li D; Roetzheim RG; Drews RE; McCarthy EP
Arch Phys Med Rehabil; 2008 Apr; 89(4):595-601. PubMed ID: 18373987
[TBL] [Abstract][Full Text] [Related]
16. Causes of death and competing risk analysis of the associated factors for non-small cell lung cancer using the Surveillance, Epidemiology, and End Results database.
Wei S; Tian J; Song X; Wu B; Liu L
J Cancer Res Clin Oncol; 2018 Jan; 144(1):145-155. PubMed ID: 28980067
[TBL] [Abstract][Full Text] [Related]
17. Improving survival for stage IV non-small cell lung cancer: a surveillance, epidemiology, and end results survey from 1990 to 2005.
Morgensztern D; Waqar S; Subramanian J; Gao F; Govindan R
J Thorac Oncol; 2009 Dec; 4(12):1524-9. PubMed ID: 19752759
[TBL] [Abstract][Full Text] [Related]
18. Survival and Racial Differences of Non-Small Cell Lung Cancer in the United States Military.
Brzezniak C; Satram-Hoang S; Goertz HP; Reyes C; Gunuganti A; Gallagher C; Carter CA
J Gen Intern Med; 2015 Oct; 30(10):1406-12. PubMed ID: 25805503
[TBL] [Abstract][Full Text] [Related]
19. Outcomes after adjuvant platinum-based chemotherapy in elderly NSCLC patients with T4 disease.
Sigel K; Mhango G; Cohen J; Halm EA; Mandeli J; Strauss G; Wisnivesky J
Ann Surg Oncol; 2013 Mar; 20(3):1013-9. PubMed ID: 23115004
[TBL] [Abstract][Full Text] [Related]
20. Retrospective study of the incidence and outcomes from lung cancer in solid organ transplant recipients.
Young K; Jiang H; Marquez M; Yeung J; Shepherd FA; Renner E; Keshavjee S; Kim J; Ross H; Aliev T; Liu G; Leighl NB; Feld R; Bradbury P
Lung Cancer; 2020 Sep; 147():214-220. PubMed ID: 32738417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
